REPORT ID 3871

Asia-Pacific Drugs for Malaria Market Report 2017

Publish Date
14-Dec-17
Pages
101
Format
Electronic (PDF)

In this report, the Asia-Pacific Drugs for Malaria market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Drugs for Malaria for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Drugs for Malaria market competition by top manufacturers/players, with Drugs for Malaria sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Cipla
    Guilin Pharmaceutical
    IPCA Laboratories
    GlaxoSmithKline
    Mylan Labs
    Roche
    Novartis
    Sanofi?Aventis
    Ajanta Pharma

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Aryl Aminoalcohol Compounds
    Antifolate Compounds
    Artemisinin Compounds

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Prevention
    Treatment
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Drugs for Malaria Market Report 2017
1 Drugs for Malaria Overview
    1.1 Product Overview and Scope of Drugs for Malaria
    1.2 Classification of Drugs for Malaria by Product Category
        1.2.1 Asia-Pacific Drugs for Malaria Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Drugs for Malaria Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Aryl Aminoalcohol Compounds
        1.2.4 Antifolate Compounds
        1.2.5 Artemisinin Compounds
    1.3 Asia-Pacific Drugs for Malaria Market by Application/End Users
        1.3.1 Asia-Pacific Drugs for Malaria Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Prevention
        1.3.3 Treatment
        1.3.4 Other
    1.4 Asia-Pacific Drugs for Malaria Market by Region
        1.4.1 Asia-Pacific Drugs for Malaria Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Drugs for Malaria (2012-2022)
        1.5.1 Asia-Pacific Drugs for Malaria Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Drugs for Malaria Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Drugs for Malaria Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Drugs for Malaria Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Drugs for Malaria Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Drugs for Malaria Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Drugs for Malaria (Volume and Value) by Type
        2.2.1 Asia-Pacific Drugs for Malaria Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Drugs for Malaria Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Drugs for Malaria (Volume) by Application
    2.4 Asia-Pacific Drugs for Malaria (Volume and Value) by Region
        2.4.1 Asia-Pacific Drugs for Malaria Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Drugs for Malaria Revenue and Market Share by Region (2012-2017)

3 China Drugs for Malaria (Volume, Value and Sales Price)
    3.1 China Drugs for Malaria Sales and Value (2012-2017)
        3.1.1 China Drugs for Malaria Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Drugs for Malaria Revenue and Growth Rate (2012-2017)
        3.1.3 China Drugs for Malaria Sales Price Trend (2012-2017)
    3.2 China Drugs for Malaria Sales Volume and Market Share by Type
    3.3 China Drugs for Malaria Sales Volume and Market Share by Application

4 Japan Drugs for Malaria (Volume, Value and Sales Price)
    4.1 Japan Drugs for Malaria Sales and Value (2012-2017)
        4.1.1 Japan Drugs for Malaria Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Drugs for Malaria Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Drugs for Malaria Sales Price Trend (2012-2017)
    4.2 Japan Drugs for Malaria Sales Volume and Market Share by Type
    4.3 Japan Drugs for Malaria Sales Volume and Market Share by Application

5 South Korea Drugs for Malaria (Volume, Value and Sales Price)
    5.1 South Korea Drugs for Malaria Sales and Value (2012-2017)
        5.1.1 South Korea Drugs for Malaria Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Drugs for Malaria Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Drugs for Malaria Sales Price Trend (2012-2017)
    5.2 South Korea Drugs for Malaria Sales Volume and Market Share by Type
    5.3 South Korea Drugs for Malaria Sales Volume and Market Share by Application

6 Taiwan Drugs for Malaria (Volume, Value and Sales Price)
    6.1 Taiwan Drugs for Malaria Sales and Value (2012-2017)
        6.1.1 Taiwan Drugs for Malaria Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Drugs for Malaria Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Drugs for Malaria Sales Price Trend (2012-2017)
    6.2 Taiwan Drugs for Malaria Sales Volume and Market Share by Type
    6.3 Taiwan Drugs for Malaria Sales Volume and Market Share by Application

7 India Drugs for Malaria (Volume, Value and Sales Price)
    7.1 India Drugs for Malaria Sales and Value (2012-2017)
        7.1.1 India Drugs for Malaria Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Drugs for Malaria Revenue and Growth Rate (2012-2017)
        7.1.3 India Drugs for Malaria Sales Price Trend (2012-2017)
    7.2 India Drugs for Malaria Sales Volume and Market Share by Type
    7.3 India Drugs for Malaria Sales Volume and Market Share by Application

8 Southeast Asia Drugs for Malaria (Volume, Value and Sales Price)
    8.1 Southeast Asia Drugs for Malaria Sales and Value (2012-2017)
        8.1.1 Southeast Asia Drugs for Malaria Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Drugs for Malaria Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Drugs for Malaria Sales Price Trend (2012-2017)
    8.2 Southeast Asia Drugs for Malaria Sales Volume and Market Share by Type
    8.3 Southeast Asia Drugs for Malaria Sales Volume and Market Share by Application

9 Australia Drugs for Malaria (Volume, Value and Sales Price)
    9.1 Australia Drugs for Malaria Sales and Value (2012-2017)
        9.1.1 Australia Drugs for Malaria Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Drugs for Malaria Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Drugs for Malaria Sales Price Trend (2012-2017)
    9.2 Australia Drugs for Malaria Sales Volume and Market Share by Type
    9.3 Australia Drugs for Malaria Sales Volume and Market Share by Application

10 Asia-Pacific Drugs for Malaria Players/Suppliers Profiles and Sales Data
    10.1 Cipla
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Drugs for Malaria Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Cipla Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 Guilin Pharmaceutical
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Drugs for Malaria Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 IPCA Laboratories
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Drugs for Malaria Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 IPCA Laboratories Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 GlaxoSmithKline
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Drugs for Malaria Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 GlaxoSmithKline Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 Mylan Labs
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Drugs for Malaria Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 Mylan Labs Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Roche
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Drugs for Malaria Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Roche Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Novartis
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Drugs for Malaria Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Novartis Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 Sanofi?Aventis
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Drugs for Malaria Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Sanofi?Aventis Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 Ajanta Pharma
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Drugs for Malaria Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Ajanta Pharma Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview

11 Drugs for Malaria Manufacturing Cost Analysis
    11.1 Drugs for Malaria Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Drugs for Malaria

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Drugs for Malaria Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Drugs for Malaria Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Drugs for Malaria Market Forecast (2017-2022)
    15.1 Asia-Pacific Drugs for Malaria Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Drugs for Malaria Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Drugs for Malaria Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Drugs for Malaria Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Drugs for Malaria Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Drugs for Malaria Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Drugs for Malaria Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Drugs for Malaria Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Drugs for Malaria Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Drugs for Malaria Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Drugs for Malaria Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Drugs for Malaria Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Drugs for Malaria Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Drugs for Malaria Sales, Revenue and Growth Rate Forecast (2017-2022)
    15.3 Asia-Pacific Drugs for Malaria Sales, Revenue and Price Forecast by Type (2017-2022)
        15.3.1 Asia-Pacific Drugs for Malaria Sales Forecast by Type (2017-2022)
        15.3.2 Asia-Pacific Drugs for Malaria Revenue Forecast by Type (2017-2022)
        15.3.3 Asia-Pacific Drugs for Malaria Price Forecast by Type (2017-2022)
    15.4 Asia-Pacific Drugs for Malaria Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer